Exclusive Page > Reuters Health News

WASHINGTON (Reuters) - The Obama administration forged ahead with healthcare reforms on Wednesday, announcing a November 16 deadline for state governments to submit proposals showing how they intend to operate health insurance exchanges in 2014.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/gsgHrsYSgD0/us-usa-healthcare-exchanges-idUSBRE84F1BM20120516

NEW YORK (Reuters) - Traumatic brain injury, the signature wound of the Iraq and Afghanistan wars, is doubly cruel: it leaves many victims emotionally shattered and cognitively crippled. But because mild and moderate brain injuries do not show up on CT or other imaging, doctors and even family members are often skeptical that any real damage exists.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/hIyUchY76Nw/us-brain-trauma-idUSBRE84F12120120516

(Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/qVJ_s98Smi0/us-cancer-jj-prostate-idUSBRE84F1FE20120516

(Reuters) - Older people who reported drinking a few daily cups of coffee were less likely to die over the subsequent 14 years than were those who abstained from the beverage or rarely drank it, according to a U.S. study of 400,000 people.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/MWNnDKWHL2o/us-coffee-idUSBRE84G00120120517

(Reuters) - Array BioPharma Inc's experimental lung cancer drug, selumetinib, w as shown to increase survival by an additional 4.2 months over chemotherapy alone, according to new data released on Wednesday.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/DbjXnPH0XT8/us-cancer-lung-array-idUSBRE84F1K920120516

(Reuters) - Roche Holding AG's new drug for advanced melanoma, Zelboraf, on average helped patients with the deadly disease live for more than a year, according to data from a late-stage trial.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/Go7_teRAYtg/us-cancer-roche-melanoma-idUSBRE84F1FC20120516

(Reuters) - Two drugs being developed by GlaxoSmithKline Plc - each designed to block different pathways used by cancer cells - have been shown in a small clinical trial to curb melanoma with fewer side effects than current therapies.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/JvDOQuFtlgc/us-cancer-glaxo-melanoma-idUSBRE84F1FO20120516

(Reuters) - A Pfizer Inc lung cancer drug appears to be a highly effective treatment for children with a rare but aggressive type of lymphoma and other cancers, according to data from an early stage study released on Wednesday.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/e8yeuJQqEKE/us-cancer-pfizer-children-idUSBRE84F1FA20120516

NEW YORK (Reuters Health) - In a new study of 400,000 older Americans, those who reported drinking a few daily cups of coffee were less likely to die over the next 14 years than were those who abstained from the beverage or rarely drank it.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/U7WasJAVR6w/us-study-death-coffee-idUSBRE84F1DK20120516

NEW YORK (Reuters Health) - The United States foreign aid program that sends billions of dollars to African countries for HIV treatment and prevention has cut the number of people dying for any reason in those nations, a new study suggests.

..

Details: http://feeds.reuters.com/~r/reuters/healthNews/~3/tx9mAGy0saQ/us-hiv-deaths-idUSBRE84E1AK20120516